Peter C Farrell - Net Worth and Insider Trading
Peter C Farrell Net Worth
The estimated net worth of Peter C Farrell is at least $24 Million dollars as of 2024-11-08. Peter C Farrell is the Director of ResMed Inc and owns about 85,204 shares of ResMed Inc (RMD) stock worth over $21 Million. Peter C Farrell is the Director of Arcturus Therapeutics Holdings Inc and owns about 95,565 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $2 Million. Peter C Farrell is also the Director of Evolus Inc and owns about 44,881 shares of Evolus Inc (EOLS) stock worth over $641,349. Details can be seen in Peter C Farrell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter C Farrell has not made any transactions after 2024-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter C Farrell
Peter C Farrell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter C Farrell owns 4 companies in total, including Arcturus Therapeutics Holdings Inc (ARCT) , Evolus Inc (EOLS) , and ResMed Inc (RMD) among others .
Click here to see the complete history of Peter C Farrell’s form 4 insider trades.
Insider Ownership Summary of Peter C Farrell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc | 2019-08-20 | director |
EOLS | Evolus Inc | 2022-09-06 | director |
RMD | ResMed Inc | 2024-10-02 | director |
2005-01-03 | director |
Peter C Farrell Latest Holdings Summary
Peter C Farrell currently owns a total of 3 stocks. Among these stocks, Peter C Farrell owns 85,204 shares of ResMed Inc (RMD) as of October 2, 2024, with a value of $21 Million and a weighting of 89.7%. Peter C Farrell owns 95,565 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of August 20, 2019, with a value of $2 Million and a weighting of 7.59%. Peter C Farrell also owns 44,881 shares of Evolus Inc (EOLS) as of September 6, 2022, with a value of $641,349 and a weighting of 2.72%.
Latest Holdings of Peter C Farrell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RMD | ResMed Inc | 2024-10-02 | 85,204 | 248.54 | 21,176,602 |
ARCT | Arcturus Therapeutics Holdings Inc | 2019-08-20 | 95,565 | 18.75 | 1,791,366 |
EOLS | Evolus Inc | 2022-09-06 | 44,881 | 14.29 | 641,349 |
Holding Weightings of Peter C Farrell
Peter C Farrell Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter C Farrell has made a total of 4 transactions in ResMed Inc (RMD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in ResMed Inc is the sale of 2,000 shares on October 2, 2024, which brought Peter C Farrell around $474,400.
According to the SEC Form 4 filings, Peter C Farrell has made a total of 0 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years. The most-recent trade in Arcturus Therapeutics Holdings Inc is the acquisition of 9,113 shares on August 20, 2019, which cost Peter C Farrell around $99,696.
According to the SEC Form 4 filings, Peter C Farrell has made a total of 1 transactions in Evolus Inc (EOLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Evolus Inc is the acquisition of 10,000 shares on September 6, 2022, which cost Peter C Farrell around $91,000.
Insider Trading History of Peter C Farrell
- 1
Peter C Farrell Trading Performance
GuruFocus tracks the stock performance after each of Peter C Farrell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter C Farrell is -14.37%. GuruFocus also compares Peter C Farrell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter C Farrell within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter C Farrell's insider trading performs compared to the benchmark.
Performance of Peter C Farrell
Peter C Farrell Ownership Network
Ownership Network List of Peter C Farrell
Ownership Network Relation of Peter C Farrell
Peter C Farrell Owned Company Details
What does Arcturus Therapeutics Holdings Inc do?
Who are the key executives at Arcturus Therapeutics Holdings Inc?
Peter C Farrell is the director of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , Chief Financial Officer Andy Sassine , and See Remarks Keith C Kummerfeld .
Arcturus Therapeutics Holdings Inc (ARCT) Insider Trades Summary
Over the past 18 months, Peter C Farrell made no insider transaction in Arcturus Therapeutics Holdings Inc (ARCT). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 139,114 shares made by Pad Chivukula , a net sale of 50,000 shares made by Andy Sassine , and a net sale of 6,968 shares made by Keith C Kummerfeld .
In summary, during the past 3 months, insiders sold 12,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 196,082 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,082 shares.
Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcturus Therapeutics Holdings Inc Insider Transactions
Peter C Farrell Mailing Address
Above is the net worth, insider trading, and ownership report for Peter C Farrell. You might contact Peter C Farrell via mailing address: Resmed Inc, 14040 Danielson Street, Poway Ca 92064-6857.